Related Experiment Video
Updated: May 1, 2026

Correlative Confocal and 3D Electron Microscopy of a Specific Sensory Cell
Published on: July 19, 2015
Peptide YY abnormalities in gastrointestinal diseases.
Plasma concentrations of peptide YY (PYY) were significantly elevated in patients with steatorrhea due to small intestinal atrophy or pancreatitis. These findings offer insights into PYY
Area of Science:
- Gastroenterology
- Endocrinology
- Peptide Research
Background:
- Peptide YY (PYY) is a newly isolated peptide hormone.
- PYY is produced by endocrine cells in the ileum and colon.
- Its role in digestive disorders requires further elucidation.
Purpose of the Study:
- To measure plasma PYY concentrations in patients with various digestive disorders.
- To investigate the relationship between PYY levels and conditions like steatorrhea.
- To explore the physiological role of PYY in intestinal adaptation.
Main Methods:
- Standardized breakfast test administered to patient groups and healthy controls.
- Measurement of plasma PYY concentrations using established assays.
- Comparison of basal and postprandial PYY levels across different patient cohorts.
Main Results:
- Grossly elevated basal PYY levels (79 ± 18 pM) in patients with steatorrhea from tropical sprue, nearly 10-fold higher than controls (8.5 ± 0.8 pM).
- Substantially increased basal PYY (47.5 ± 6.3 pM) and exaggerated postprandial response in chronic destructive pancreatitis.
- Moderately elevated PYY in inflammatory bowel disease and recovering infective diarrhea; normal responses in diverticular disease, duodenal ulcer, and functional bowel disease.
Conclusions:
- Plasma PYY levels are significantly altered in specific digestive disorders, particularly those associated with steatorrhea.
- Elevated PYY may indicate impaired intestinal function or adaptation.
- Further research into PYY secretion patterns can illuminate its physiological role and implications for digestive health.
More Related Videos
06:26Use of Anti-phospho-girdin Antibodies to Visualize Intestinal Tuft Cells in Free-Floating Mouse Jejunum Cryosections
Published on: March 21, 2018
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Related Concept Videos
Gastrointestinal Motility Disorders
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis II: Pathophysiology
Pyloric Obstruction
Peptic Ulcer Disease I: Introduction